Price movement over the last 24 hours
ARK Genomic Revolution ETF vs YieldMax COIN Option Income Strategy ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while YieldMax COIN Option Income Strategy ETF trades at $19.45. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, YieldMax COIN Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | CONY | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $43.57 | $103.20 |
52-Week Low | $23.09 | $18.43 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
CONY trades at $19.63 with a modest 0.31% daily gain. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. The ETF maintains a high distribution yield strategy, with recent weekly dividends ranging from $0.24 to $0.56. Financial ratios are unavailable in the current dataset, limiting fundamental assessment.
The outlook remains cautious due to the bearish technical setup and concerns about long-term sustainability of high distributions amid underlying asset volatility. While the yield strategy attracts income-focused investors, the 37% decline noted in recent analysis highlights significant price erosion that distributions have not offset.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →CONY is an actively managed ETF that seeks to generate weekly income by selling call options on Coinbase (COIN) stock. It aims to provide high yield while maintaining exposure to the price movements of the crypto exchange.
Read more on CONY →